Viral Hepatitis

You have full text access to this OnlineOpen article

Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation†

  1. José A. Carrión1,
  2. Ferran Torres2,
  3. Gonzalo Crespo1,
  4. Rosa Miquel3,
  5. Juan-Carlos García-Valdecasas4,
  6. Miquel Navasa1,‡,*,
  7. Xavier Forns1

Article first published online: 18 OCT 2009

DOI: 10.1002/hep.23240

Issue

Hepatology

Hepatology

Volume 51, Issue 1, pages 23–34, January 2010

Additional Information

How to Cite

Carrión, J. A., Torres, F., Crespo, G., Miquel, R., García-Valdecasas, J.-C., Navasa, M. and Forns, X. (2010), Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation. Hepatology, 51: 23–34. doi: 10.1002/hep.23240

Author Information

  1. 1

    Liver Unit, Institut de Malalties Digestives, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain

  2. 2

    Laboratory of Biostatistics and Epidemiology (Universitat Autònoma de Barcelona); Statistics and Methodology Support Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain

  3. 3

    Pathology Unit, Hospital Clínic, IDIBAPS, CIBERehd, Barcelona, Spain

  4. 4

    Liver Transplantation and Hepatic Surgery Department, Hospital Clínic, IDIBAPS, CIBERehd, Barcelona, Spain

  1. ‡

    telephone: 34 03 227 54 99; fax: +34 93 451 55 22.

*Liver Unit, ICMD, Hospital Clinic, IDIBAPS and CIBERehd, Villarroel 170, 08036 Barcelona, Spain

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 23 DEC 2009
  2. Article first published online: 18 OCT 2009
  3. Manuscript Accepted: 10 AUG 2009
  4. Manuscript Received: 17 APR 2009

Funded by

  • Schering and Roche
  • Fundación BBVA
  • Instituto de Salud Carlos III. Grant Numbers: PI050230, PI080239

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (611K)

References

  • 1
    Garcia-Retortillo M, Forns X, Feliu A, Moitinho E, Costa J, Navasa M, et al. Hepatitis C virus kinetics during and immediately after liver transplantation. HEPATOLOGY 2002; 35: 680–687.
    Direct Link:
  • 2
    Garcia-Retortillo M, Forns X. Prevention and treatment of hepatitis C virus recurrence after liver transplantation. J Hepatol 2004; 41: 2–10.
  • 3
    Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. HEPATOLOGY 1999; 29: 250–256.
    Direct Link:
  • 4
    Sanchez-Fueyo A, Restrepo JC, Quinto L, Bruguera M, Grande L, Sanchez-Tapias JM, et al. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft1. Transplantation 2002; 73: 56–63.
  • 5
    Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889–896.
  • 6
    Samuel D, Bizollon T, Feray C, Roche B, Ahmed SN, Lemonnier C, et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 2003; 124: 642–650.
  • 7
    Chalasani N, Manzarbeitia C, Ferenci P, Vogel W, Fontana RJ, Voigt M, et al. Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials. HEPATOLOGY 2005; 41: 289–298.
    Direct Link:
  • 8
    Carrion JA, Navasa M, Garcia-Retortillo M, Garcia-Pagan JC, Crespo G, Bruguera M, et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology 2007; 132: 1746–1756.
  • 9
    Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayon M, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673–684.
  • 10
    Neumann UP, Berg T, Bahra M, Seehofer D, Langrehr JM, Neuhaus R, et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 2004; 41: 830–836.
  • 11
    Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. HEPATOLOGY 2003; 38: 1449–1457.
  • 12
    Rousselet MC, Michalak S, Dupre F, Croue A, Bedossa P, Saint-Andre JP, et al. Sources of variability in histological scoring of chronic viral hepatitis. HEPATOLOGY 2005; 41: 257–264.
    Direct Link:
  • 13
    Blasco A, Forns X, Carrion JA, Garcia-Pagan JC, Gilbert R, Rimola A, et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. HEPATOLOGY 2006; 43: 492–499.
    Direct Link:
  • 14
    Benlloch S, Berenguer M, Prieto M, Rayon JM, Aguilera V, Berenguer J. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index. Liver Transpl 2005; 11: 456–462.
    Direct Link:
  • 15
    Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, et al. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation. J Gastroenterol Hepatol 2007; 22: 1904–1908.
    Direct Link:
  • 16
    Pungpapong S, Nunes DP, Krishna M, Nakhleh R, Chambers K, Ghabril M, et al. Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C. Liver Transpl 2008; 14: 1294–1302.
    Direct Link:
  • 17
    Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 2007; 7: 40.
  • 18
    Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. HEPATOLOGY 2007; 46: 912–921.
    Direct Link:
  • 19
    Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004; 127: 1704–1713.
  • 20
    Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705–1713.
  • 21
    Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. HEPATOLOGY 2005; 41: 48–54.
    Direct Link:
  • 22
    Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343–350.
  • 23
    Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006; 12: 1791–1798.
    Direct Link:
  • 24
    Harada N, Soejima Y, Taketomi A, Yoshizumi T, Ikegami T, Yamashita YI, et al. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation. Transplantation 2008; 85: 69–74.
  • 25
    Rigamonti C, Donato MF, Fraquelli M, Agnelli F, Ronchi G, Casazza G, et al. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation. Gut 2008; 57: 821–827.
  • 26
    Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. HEPATOLOGY 2007; 45: 1290–1297.
    Direct Link:
  • 27
    Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 2008; 27: 1261–1268.
  • 28
    Garcia-Retortillo M, Forns X, Llovet JM, Navasa M, Feliu A, Massaguer A, et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. HEPATOLOGY 2004; 40: 699–707.
    Direct Link:
  • 29
    Gane EJ. The natural history of recurrent hepatitis C and what influences this. Liver Transpl 2008; 14(Suppl. 2): S36–S44.
  • 30
    Scheuer PJ. The nomenclature of chronic hepatitis: time for a change. J Hepatol 1995; 22: 112–114.
  • 31
    Theise ND. Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol 2007; 20(Suppl. 1): S3–S14.
  • 32
    Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. HEPATOLOGY 2008; 47: 380–384.
    Direct Link:
  • 33
    Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007; 14: 360–369.
    Direct Link:
  • 34
    Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. HEPATOLOGY 2008; 47: 592–595.
    Direct Link:
  • 35
    Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouilleres O, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. HEPATOLOGY 2006; 43: 1118–1124.
    Direct Link:
  • 36
    Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. HEPATOLOGY 2002; 36: 202–210.
    Direct Link:
  • 37
    Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 2002; 8: 362–369.
    Direct Link:
  • 38
    Samonakis DN, Cholongitas E, Thalheimer U, Kalambokis G, Quaglia A, Triantos CK, et al. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis. Liver Transpl 2007; 13: 1305–1311.
    Direct Link:
  • 39
    Navasa M, Forns X. How accurately and how early can we predict rapid fibrosis progression in hepatitis C virus-infected patients after liver transplantation? Liver Transpl 2008; 14: 1237–1239.
    Direct Link:
View Full Article (HTML) Get PDF (611K)